The present invention relates to methods for generating limited chemical diversity for biologically relevant lead molecules by late state functionalization, separation, and post-functionalization modification. The methods optionally include one or more screening steps. Traditional drug development has relied on the synthesis of individual compounds or the generation of large chemical libraries, but these methods have generally been fairly inefficient in obtaining drug products.
本发明涉及通过后期功能化、分离和后功能化修饰来生成具有
生物学相关性的引物分子的有限
化学多样性的方法。这些方法可选地包括一个或多个筛选步骤。传统药物开发依赖于合成单个化合物或生成大型
化学库,但这些方法通常在获得药物产品方面效率较低。